Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate; Rivaroxaban; Warfarin
- Indications Stroke; Thromboembolism; Thrombosis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 07 Jul 2017 Planned End Date changed from 1 Jun 2017 to 30 Mar 2018.
- 07 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 30 Mar 2018.
- 03 May 2016 New trial record